From: Concurrent infections of dengue virus serotypes in Bali, Indonesia
Variable | Mono-infection cases (N = 182) | Concurrent infections cases (N = 8) |
---|---|---|
Demography and clinical manifestations | ||
Age, median year (range) | 28 (14–75) | 42 (25–53) |
Male, N (%) | 80 (44.0) | 7 (87.5) |
Female, N (%) | 102 (56.0) | 1 (12.5) |
Fever day, days ± SD | 3.3 ± 0.83 | 2.0 ± 0.93 |
Headache | 139 (76.4) | 7 (87.5) |
Arthralgia | 101 (55.5) | 6 (75.0) |
Myalgia | 122 (67.0) | 6 (75.0) |
Vomiting | 92 (50.5) | 2 (25.0 |
Bleeding | 46 (25.3) | 2 (25.0) |
Plasma leakage | 0 (0.0) | 0 (0.0) |
Shock | 0 (0.0) | 0 (0.0) |
Laboratory examinations data | ||
Nadir WBC (× 10 µg/µL), median (range) | 2.1 (0.48–6.4) | 2.77 (1.16–4.1) |
HCT difference (%), median (range) | 13.1 (2.43–68.9) | 11.5 (6.1–21.4) |
Nadir PLT (× 109/L), median (range) | 43 (6–194) | 102 (16–122) |
DENV NS1 test positivity, N (%) | 173 (95.1) | 8 (100.0) |
Dengue IgM positivity, N (%) | 123 (67.6) | 7 (87.5) |
Dengue IgG positivity, N (%) | 142 (78.0) | 5 (62.5) |
Dengue severity | ||
DF, N (%) | 110 (60.4) | 6 (75.0) |
DHF grade 1, N (%) | 42 (23.1) | 2 (25.0) |
DHF grade 2, N (%) | 26 (14.3) | 0 (0.0) |
DHF grade 3, N (%) | 4 (2.2) | 0 (0.0) |
DHF grade 4, N (%) | 0 (0.0) | 0 (0.0) |